trial

Beware of Fake Shark Tank Trial Supplements

10/17/2020, Denver // KISSPR //

According to a host of recent statistical data, the relationship between ABC’s famous reality TV show Shark Tank and Keto diet pills seems to be at an all-time high. For those of our readers who may not be aware, Shark Tank is a television-based investment platform designed for entrepreneurs to pitch their ideas to several seasoned venture capitalists (like Mark Cuban, Kevin O’Leary) and take their business ideas to the next level.

In this regard, while there have been quite a few health and fitness-related products that have been introduced in front of the judges’ panel as part of Shark Tank, there has only ever been one keto diet supplement brand to grace the program. However, if one were to do a quick search online, it would appear as though there have been numerous such supplements that made their way onto the show. So in

Read More

I volunteered for a COVID-19 vaccine trial in New Jersey. Here’s what it’s been like since the shot.

On the afternoon of Sept. 22, I became a data point in the search for a vaccine to prevent COVID-19.

That’s when I received the first of two shots in a clinical trial to develop a vaccine, and became one of 30,000 volunteers to take a needlestick for science.

Why am I doing it? A combination of altruism, curiosity, and a sense of duty as a journalist. But more on that later.

Aside from the nurse who injected me and the hospital pharmacy that supplied her with the injection, no one else knows whether I received a placebo or the would-be vaccine. Not me. Not even Dr. Bindu Balani, the principal investigator in the trial at Hackensack University Medical Center, one of 89 study sites around the country.

This is called a double-blind study because both the researchers and the participants are blind to what was inside that syringe.

I

Read More

J&J has started its late-stage coronavirus vaccine trial

Welcome to Business Insiders daily healthcare newsletter, your daily dose of pharma, biotech, and healthcare news. Subscribe here to get this newsletter in your inbox every weekday.

<p class="copyright">Hollis Johnson/Business Insider</p>

Hello,

Today in healthcare news: GoodRx is making its stock-market debut after pricing shares at $33 apiece just after midnight. At that price, the company is valued at $12.7 billion. What a time to be in the digital health/online prescription drug coupon business. 

Also: Johnson & Johnson has started a 60,000-person coronavirus vaccine trial, coronavirus deaths passed 200,000, and your ultimate guide to reading through vaccine data. 

Speaking of vaccines (and when are we not!):  Our biotech reporter Andrew Dunn is moderating a conversation on October 5 at 2 p.m. ET on the coronavirus vaccine race with 3 top experts:

  • Maria Elena Bottazzi, co-director of Texas Children’s Hospital Center for Vaccine Development

  • Art Caplan, bioethicist and

Read More

Vaccine trial results could come in November; thousands of health workers have died; cases in Europe up

As the race to find a coronavirus vaccine continues, the World Health Organization on Thursday announced grim reminders of COVID-19’s global impact.

The WHO said cases are surging again in Europe, with more than half of European countries seeing a 10% or greater spike in cases. COVID-19 is also disproportionately affecting healthcare workers, according to WHO data. 

Health workers make up 2-3% of the global population but account for about 14% of reported COVID-19 cases. “Thousands of health workers infected with COVID-19 have lost their lives worldwide,” the organization said.

Meanwhile, progress towards a vaccine continued Thursday: Moderna said it was moving up its trial results timeline. The company said it could have enough clinical trial results for its candidate vaccine as soon as November.

That news followed cautions from Robert Redfield, director of the Centers for Disease Control and Prevention, on Wednesday. Redfield urged the use of face masks

Read More

AstraZeneca resumes vaccine trial; Puerto Rico reopens beaches; US downgrades Mexico travel warning

Drug developers are racing to create a COVID-19 vaccine, but a post-pandemic world won’t suddenly arrive when one is successfully developed. 

But a return to “normal living” won’t come until “several months” after a vaccine first arrives, Dr. Anthony Fauci said on CNN. That’s likely to be about a year away, as a successful vaccine still needs to be manufactured and distributed at a massive scale.

In the meantime, Americans are learning more about risks associated with several parts of normal life that remain. Recent Centers for Disease Control and Prevention studies documented health challenges in dining and daycare. One study found dining out was linked with higher infection rates in adults. Another study documented children who were infected in daycare and spread the virus at home. 

Meanwhile colleges continue to be hotspots for the virus: Of the 25 hottest outbreaks in the U.S., communities heavy with college students

Read More

Why volunteer for a vaccine clinical trial? Duty, love and a willingness to experiment, participants say

Esther Aviles wants to help her special needs students and her nine nieces and nephews.

Joseph Shilisky believes the world needs ordinary people like him to step up. 

Robert Huebner likes to be among the first, whether it’s the first to try a new computer game, a new restaurant, or – now – a new vaccine.

All three are among the early volunteers in clinical trials to test potential COVID-19 vaccines. Vaccine developers have already shown basic safety, with no severe reactions in early trials. And they’ve shown their candidate vaccines trigger the kind of immune response they want to see.

Race to the vaccine

The first of an occasional USA TODAY series about efforts to rapidly develop and deliver a vaccine against the coronavirus.

But to meet scientific standards of safety and effectiveness, each candidate has to be tested in thousands of people, most of whom will get two

Read More

Vice President Pence visits Miami for launch of Phase 3 of COVID vaccine clinical trial

With President Donald Trump’s poll numbers flagging in Florida as the state continues to struggle with one of the nation’s highest rates of new COVID-19 cases, Vice President Mike Pence visited the University of Miami’s Miller School of Medicine on Monday afternoon to focus attention on one of the pandemic’s few potential bright spots: the rapid development of a vaccine against the disease.

Pence touched down at Miami International Airport at about 12:30 p.m. on Monday. He walked off the plane with Dr. Stephen Hahn, commissioner of the U.S. Food and Drug Administration. Both wore masks, as is required in public in Miami-Dade County under an order from Miami-Dade Mayor Carlos Gimenez, who greeted the vice president at the plane along with Florida Gov. Ron DeSantis. DeSantis and Gimenez wore masks.

Pence greeted DeSantis and Gimenez by bumping forearms. They spoke on the runway for about five minutes, reviewed a

Read More

Tesco starts online refillable container trial

Tesco is trialling a scheme in the UK where online shoppers will get products in reusable packaging.

The supermarket giant is joining forces with Loop, which styles itself as a “zero waste shopping platform”.

The trial covers 150 items, which will be delivered in reusable containers for which consumers pay a deposit.

Greenpeace said rising demand for home deliveries due to the lockdown gave “a real opportunity for innovation in reusable packaging”.

Tom Szaky, the chief executive of Loop, said the UK service would start off as a pilot, but would be delivering to the whole of the UK mainland, including Northern Ireland.

Customers will apply for the service by clicking on a link on the Tesco website, and will then be able to order their delivery, which will come in a bag via courier firm DPD.

After using the products, which include Heinz Tomato Ketchup, Persil washing liquid, Coca-Cola,

Read More

Tesco launches online refillable container trial

Tesco is trialling a scheme in the UK where online shoppers will get products in reusable packaging.

The supermarket giant is joining forces with Loop, which styles itself as a “zero waste shopping platform”.

The trial covers 150 items, which will be delivered in reusable containers for which consumers pay a deposit.

Greenpeace said rising demand for home deliveries due to the lockdown gave “a real opportunity for innovation in reusable packaging”.

Tom Szaky, the chief executive of Loop, said the UK service would start off as a pilot, but would be delivering to the whole of the UK mainland, including Northern Ireland.

Customers will apply for the service by clicking on a link on the Tesco website, and will then be able to order their delivery, which will come in a bag via courier firm DPD.

After using the products, which include Heinz Tomato Ketchup, Persil washing liquid, Coca-Cola,

Read More